The FDA set a PDUFA date in late 2025 as ziftomenib led to significant disease response in patients with common subtype of ...

Shares of Sun Pharma Advanced Research Company Ltd (SPARC) plunged nearly 20% on Wednesday on the NSE, after the company ...

The trial is expected to generate significant clinical data by late summer 2026. Allarity plans to pursue multiple advantaged ...

Actuate Therapeutics has set its sights on getting elraglusib approved for pancreatic cancer after the glycogen synthase ...

Shares of Sun Pharma Advanced Research Company (SPARC), the research division of India’s largest pharmaceutical firm Sun Pharma, fell 19 per cent to Rs 158 each after unsatisfactory Phase 2 trial ...

Sempra's Port Arthur Phase 2 project in Texas has won U.S. approval to export liquefied natural gas to markets in Europe and ...

"To enroll our first patients just over two months after announcing our $110 million Series B round demonstrates the Curevo ...

Dart has awarded a 12-year contract to a local firm, Mofat Company Limited, to operate Phase II of the Bus Rapid Transit (BRT ...

Sempra (NYSE:SRE) said Thursday the U.S. Department of Energy issued a permit allowing its Port Arthur LNG Phase 2 ...